QL1706 Plus Chemotherapy With AG Regime as First-line Treatment of Advanced PDAC

NCT06750861 · clinicaltrials.gov ↗

PHASE2

Phase

NOT_YET_RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Adenocarcinoma

Interventions

DRUG: QL1706

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences